Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the top gene therapy stocks to buy according to hedge funds. On February 17, ...

Researchers at Vilnius University (Lithuania) have uncovered how the bacterial protein Cas9, better known as the CRISPR-Cas ...

Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually by 2050. Now, scientists at UC San Diego have unveiled a powerful new CRISPR ...

Investors have bought into the promise of CRISPR technology for years. The ability to target and edit genes to treat cancer ...

The global CRISPR technology market is expected to witness a growth rate of 16% in the next five years. Continuous advancements in CRISPR technology; rising demand for precise and efficient ...

"CRISPR is a gene-editing tool that makes precise DNA changes, advancing drug development, crop improvement, and disease research. It opens new business opportunities and offers solutions for genetic ...

One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand treatment to others.

The global CRISPR technology market is poised for strong expansion, projected to grow at a robust CAGR of approximately 16% over the next five years. This growth is fueled by continuous advancements ...

In the wake of the germline editing controversy, when Chinese scientist He Jianku illegally edited the embryos of human twins ...